Serum sex hormones and measures of benign prostatic hyperplasia

Rosebud O. Roberts, Debra J. Jacobson, Thomas Rhodes, George G. Klee, Michael M. Leiber, Steven J. Jacobsen

Research output: Contribution to journalArticle

84 Scopus citations

Abstract

BACKGROUND. Despite biologic plausibility, the associations between sex hormones and measures of benign prostatic hyperplasia (BPH) have not been consistently reported. METHODS. Subjects were randomly selected from the Olmsted County, MN population (n, 320; median age, 60.9 years) and followed biennially since 1990. In 2002, surrogate measures of BPH were assessed from an approximation of the American Urological Association Symptom Index (AUASI), Peak urinary flow rates (Qmax), and a transrectal ultrasound assessment of prostate volume. Serum levels of prostate specific antigen (PSA), testosterone, bioavailable testosterone, and estradiol were also measured. RESULTS. Bioavailable testosterone levels declined with increasing cross-sectional age from 53.8, 50.2, to 41.2 ng/dl (P = 0.001) in men aged <60, 60-69, and >69 years, respectively, and the estradiol/bioavailable testosterone ratio increased from 0.042, 0.044, to 0.050 (P = 0.04). Among men with bioavailable testosterone above the median, estradiol levels had a dose response relationship with prostate size. Among men with bioavailable testosterone level ≤ the median, however, there was no association between estradiol level and prostate volume CONCLUSIONS. While cross-sectional, these findings suggest a more complex relationship between sex steroids and prostate volume in older men than simple independent effects.

Original languageEnglish (US)
Pages (from-to)124-131
Number of pages8
JournalProstate
Volume61
Issue number2
DOIs
StatePublished - Oct 1 2004

Keywords

  • Benign prostatic hyperplasia
  • Cross-sectional
  • Peak flow rate
  • Prostate volume
  • Sex hormones
  • Symptoms

ASJC Scopus subject areas

  • Oncology
  • Urology

Fingerprint Dive into the research topics of 'Serum sex hormones and measures of benign prostatic hyperplasia'. Together they form a unique fingerprint.

  • Cite this

    Roberts, R. O., Jacobson, D. J., Rhodes, T., Klee, G. G., Leiber, M. M., & Jacobsen, S. J. (2004). Serum sex hormones and measures of benign prostatic hyperplasia. Prostate, 61(2), 124-131. https://doi.org/10.1002/pros.20080